Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
- PMID: 29746564
- PMCID: PMC5945008
- DOI: 10.1371/journal.pone.0197127
Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
Abstract
Objective: Patients with liver cirrhosis (LC) are at increased risk for bacterial infections. It is not fully understood how exposure to infections induces further development of hepatic encephalopathy (HE). This study estimated risks of infection associated with HE among patients with LC.
Methods: A nested case-control study of 14,428 adult patients with LC was performed using the population-based Longitudinal Health Insurance Database 2000 in Taiwan. Cases were cirrhotic patients who developed HE during follow-up. Controls were matched to each case by age at LC diagnosis (±2 years), sex, Charlson Comorbid index score, year of LC, and follow-up time with a 1:1 ratio. A multivariate logistic regression model was used to determine and compare the odds of developing HE based on exposure to various risk factors, including site of infection, cirrhosis-related complications, Helicobacter pylori eradication therapy, and peptic ulcer bleeding. Patient survival was evaluated using the time-dependent Cox regression model.
Results: Cirrhotic patients with HE (n = 714) and without HE (n = 714) were matched to compare risks. Infections and more frequent yearly infections were significantly associated with increased risk of HE. Independent predictors of HE included spontaneous bacterial peritonitis (aOR, 5.13; 95% CI, 3.03-8.69), sepsis (aOR, 2.54; 95% CI, 1.82--3.53), and biliary tract infection (aOR, 2.03; 95% CI, 1.2-3.46), controlling for confounders.
Conclusion: Frequent infections are associated with increased risk of HE in cirrhotic patients. More frequent exposure to infection increases the risk of HE and mortality rates. Appropriate prevention of infection and the use of antibiotics for cirrhotic patients at risk for HE are needed.
Conflict of interest statement
Figures
References
-
- Li YY, Nie YQ, Sha WH, Zeng Z, Yang FY, Ping L, et al. (2004) Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 10: 2397–2401. doi: 10.3748/wjg.v10.i16.2397 - DOI - PMC - PubMed
-
- Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, et al. (2008) Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatol Res 38: 1069–1075. doi: 10.1111/j.1872-034X.2008.00374.x - DOI - PubMed
-
- Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3: 705–713. - PubMed
-
- Stepanova M, Mishra A, Venkatesan C, Younossi ZM (2012) In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 10: 1034–1041 e1031 doi: 10.1016/j.cgh.2012.05.016 - DOI - PubMed
-
- Poordad FF (2007) Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther 25 Suppl 1: 3–9. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
